MAPS EMEA 2025

Amplifying the Patient Voice: Reflections from MAPS EMEA 2025

At this year’s MAPS EMEA 2025 Annual Meeting in London, the message was clear: the patient voice is central to every stage of the drug development journey, a theme eloquently showcased in the Opening General Assembly: Patient Impact on Medical Affairs. Global leaders in Medical Affairs gathered to explore how the industry can evolve from…...
Read More

Top Stories

NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers )?

The theme for this year’s NASSCOM GCC Summit, “The Next GCC...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Medical Device Regulation

Clinical Evidence: How Much Is Enough?

Ensuring the safety and functionality of your medical device is vital. But how much clinical...
a-man-questioning-medical-device-regulatory-options

Which Regulatory Requirements Are Applicable to “Legacy” Devices?

Understanding the requirements for your medical device is vital in today’s market. But are these...
Medical device regulation and how the safety, performance, and RMS align

Simple Considerations before Determining S&P Objectives for Medical Devices

With all the things to consider with Medical Device Regulations, it's important to identify the...
diversity and inclusion

Promoting Diversity and Inclusion in Clinical Trials – New England Journal of Medicine’s New Policy

Read this update on how the New England Journal of Medicine is trying to promote...

MedTech Summit 2021: Understanding Post Market Clinical Follow Up (PCMF)

An ideal PMCF plan, with reference to MDCG 2020-7, presents the general and specific methods...

Bringing New Devices to Market under the EU MDR

With the MDR coming into effect, the manufacturers should plan and construct their strategy to...

Learn more ABOUT our company.